Menu

Geneticists Engineer a Virus to Fight Citrus Disease

Scientists hope to save oranges from a bacterial disease that causes citrus greening, a disease that leads to bitter, discolored fruit.

May 17, 2017
Diana Kwon

FLICKR, RAFAEL CASTILLO

Since 2005, Candidatus Liberibacter, a genus of bacteria that is spread by Asian citrus psyllids (Diaphorina citri) and turns fruit green and bitter, has been devastating orange crops in the United States. “There’s a real race on right now to try to save the citrus,” Carolyn Slupsky, a food scientist at the University of California, Davis, told Nature. “This disease is everywhere, and it’s horrible.”

To combat this rapidly spreading pathogen, scientists at the Florida-based agricultural company Southern Gardens Citrus engineered a harmless strain of the citrus tristeza virus (CTV) to produce genes isolated from spinach plants that fight off the harmful bacteria. The company plans to infect tree limbs with this virus then graft them onto the bacteria-infected trees.

“We’re attacking the bacteria where it lives, and we can do it without changing the biology of the tree at all,” Tim Eyrich, Southern Gardens’ vice president of research and commercialization, told Wired.

In February, the company applied to the US Department of Agriculture (USDA) for permission to use this technology, and field trials are currently ongoing. Last week, the required period for public comment regarding the engineered virus ended, and the USDA now will assess its potential environmental impact, according to Nature.

Other efforts to fight the plant pathogen include switching off transmission-related genes in insect vectors with RNA interference and editing citrus tree genomes with CRISPR-Cas9. “There are great scientific opportunities here,” Bryce Falk, a plant pathologist at the University of California, Davis, told Nature. “We need to take advantage of new technologies.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!